Adalimumab

At a glance
- Medicine type
- Biologic medicine
- How it is given
- Injection under the skin
- Main target
- Tumour necrosis factor
What adalimumab is
Adalimumab is a biologic medicine given by injection under the skin. It is designed to bind tumour necrosis factor, an immune messenger involved in inflammation. By reducing this signal, it can calm inflammation in selected immune-mediated conditions. It is prescribed and monitored by a clinician; it is not a general treatment for every rash or skin concern.
How adalimumab works
Adalimumab targets one inflammatory pathway rather than broadly suppressing every immune function. The medicine is supplied for self-injection or administration as directed by the treating team. The schedule, preparation, storage, and injection technique depend on the prescribed product and your care plan.
Where adalimumab is used
Dermatology teams may use adalimumab when a suitable inflammatory skin condition has not responded adequately to other approaches, or when a biologic is appropriate for the person’s clinical situation. The decision considers the diagnosis, disease activity, previous treatments, other health conditions, and infection risk. It may be part of biologic therapy.
Possible alternatives
Alternatives depend on the condition being treated. Options may include topical medicines, light-based treatment, conventional immune-modifying medicines, or another biologic with a different target. A clinician compares expected benefit, monitoring needs, injection preferences, and medical history before changing treatment.
What treatment may mean for you
Before starting, tell the treating team about infections, repeated infections, tuberculosis exposure, hepatitis history, cancer history, neurological conditions, heart problems, pregnancy plans, and all medicines. Screening and baseline checks may be recommended. Contact the team promptly if you develop a serious infection, persistent fever, unusual bruising, or another concerning change.
Ongoing use and safety
Adalimumab is continued only while its benefits and safety remain acceptable for you. Follow the prescribed schedule and monitoring plan, and do not double a missed dose without advice. Store and handle it exactly as instructed. Injection-site reactions can occur; urgent advice is needed for severe allergic symptoms or signs of a serious infection.
Find care
Dermatology & Skin Care in Dubai
Licensed dermatology & skin care listed in Dubai, for the reader who wants this looked at in person.
Wafi Mall - 1st Floor - Code “B”/ Entrance - Gate 3 Oud Metha Rd - inside the mall - Umm Hurair Second - Dubai Healthcare City - Dubai - United Arab Emirates
Accepts: Insurance Accepted
Al Ferdous 4, Al Wasl Road 603, AL SAFFA FIRST, Dubai
Accepts: Daman, Thiqa, AXA, Cigna +24 more
The mall, Jumeira Street 856a, UM SUQAIM SECOND, Dubai
Accepts: Thiqa, AXA, Bupa Global, Dubai Insurance Company +10 more
The Arcade, 4 Street 8, Al Garhoud, Dubai
Accepts: Daman, Thiqa, AXA, Cigna +26 more
Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.
A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.
Questions people ask
Is adalimumab a steroid?
No. Adalimumab is a biologic medicine that targets tumour necrosis factor; it is different from corticosteroids.
Can I start adalimumab without screening?
No. The treating team may review infection risks and recommend checks before treatment begins.
Related
Related reading
Keep reading
Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.